278 related articles for article (PubMed ID: 21241415)
1. Effect of Helicobacter pylori infection on Barrett's esophagus and esophageal adenocarcinoma formation in a rat model of chronic gastroesophageal reflux.
Liu FX; Wang WH; Wang J; Li J; Gao PP
Helicobacter; 2011 Feb; 16(1):66-77. PubMed ID: 21241415
[TBL] [Abstract][Full Text] [Related]
2. Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux.
Chu YX; Wang WH; Dai Y; Teng GG; Wang SJ
World J Gastroenterol; 2014 Nov; 20(42):15715-26. PubMed ID: 25400455
[TBL] [Abstract][Full Text] [Related]
3. [An experimental study on chemoprevention of esophageal adenocarcinoma by celecoxib, a selective cyclooxygenase-2 inhibitor].
Zhang T; Su LW; Zhu YF; Lang HJ; Zhang F; Zhou YA; Liang XH; Wang YJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 May; 15(5):512-6. PubMed ID: 22648851
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib inhibits Cdx2 expression and prevents gastric cancer in Helicobacter pylori-infected Mongolian gerbils.
Futagami S; Suzuki K; Hiratsuka T; Shindo T; Hamamoto T; Tatsuguchi A; Ueki N; Shinji Y; Kusunoki M; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
Digestion; 2006; 74(3-4):187-98. PubMed ID: 17341852
[TBL] [Abstract][Full Text] [Related]
5. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus.
Vaezi MF; Falk GW; Peek RM; Vicari JJ; Goldblum JR; Perez-Perez GI; Rice TW; Blaser MJ; Richter JE
Am J Gastroenterol; 2000 Sep; 95(9):2206-11. PubMed ID: 11007219
[TBL] [Abstract][Full Text] [Related]
6. [Chemoprevention of Barrett's esophagus by celecoxib in rats].
Wang RH; Ou-Yang Q; Chen X; Li GD; Xiang JY
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 38(5):498-504. PubMed ID: 19830863
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori induces caudal-type homeobox protein 2 and cyclooxygenase 2 expression by modulating microRNAs in esophageal epithelial cells.
Teng G; Dai Y; Chu Y; Li J; Zhang H; Wu T; Shuai X; Wang W
Cancer Sci; 2018 Feb; 109(2):297-307. PubMed ID: 29215765
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM
Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266
[TBL] [Abstract][Full Text] [Related]
9. [A COX-2 inhibitor suppresses esophageal inflammation-metaplasia-adenocarcinoma sequence in rats].
Miwa K; Oyama K; Fujimura T
Nihon Rinsho; 2005 Aug; 63(8):1387-93. PubMed ID: 16101227
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori and Barretts esophagus: a protective factor or a real cause?
Tomasello G; Giordano F; Mazzola M; Jurjus R; Jurjus A; Damiani P; Nobile S; Carini F; Leone A
J Biol Regul Homeost Agents; 2017; 31(1):9-15. PubMed ID: 28337865
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett's esophagus. Lesson from experimental animal model and human subjects.
Majka J; Rembiasz K; Migaczewski M; Budzynski A; Ptak-Belowska A; Pabianczyk R; Urbanczyk K; Zub-Pokrowiecka A; Matlok M; Brzozowski T
J Physiol Pharmacol; 2010 Aug; 61(4):409-18. PubMed ID: 20814068
[TBL] [Abstract][Full Text] [Related]
12. Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial.
Heath EI; Canto MI; Piantadosi S; Montgomery E; Weinstein WM; Herman JG; Dannenberg AJ; Yang VW; Shar AO; Hawk E; Forastiere AA;
J Natl Cancer Inst; 2007 Apr; 99(7):545-57. PubMed ID: 17405999
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori colonization of Barrett's esophagus and its progression to cancer.
Wright TA; Myskow M; Kingsnorth AN
Dis Esophagus; 1997 Jul; 10(3):196-200. PubMed ID: 9280079
[TBL] [Abstract][Full Text] [Related]
14. Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma.
Clark GW
World J Surg; 2003 Sep; 27(9):994-8. PubMed ID: 14560364
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS
Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
[TBL] [Abstract][Full Text] [Related]
16. Barrett's esophagus and the presence of Helicobacter pylori.
Henihan RD; Stuart RC; Nolan N; Gorey TF; Hennessy TP; O'Morain CA
Am J Gastroenterol; 1998 Apr; 93(4):542-6. PubMed ID: 9576445
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan.
Abe Y; Ohara S; Koike T; Sekine H; Iijima K; Kawamura M; Imatani A; Kato K; Shimosegawa T
Am J Gastroenterol; 2004 Jul; 99(7):1213-21. PubMed ID: 15233656
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori and gastroesophageal reflux disease.
Kandulski A; Malfertheiner P
Curr Opin Gastroenterol; 2014 Jul; 30(4):402-7. PubMed ID: 24848647
[TBL] [Abstract][Full Text] [Related]
19. Mucosa-associated lymphoid tissue (MALT) in Barrett's esophagus: prospective evaluation and association with gastric MALT, MALT lymphoma, and Helicobacter pylori.
Weston AP; Cherian R; Horvat RT; Lawrinenko V; Dixon A; McGregor D
Am J Gastroenterol; 1997 May; 92(5):800-4. PubMed ID: 9149188
[TBL] [Abstract][Full Text] [Related]
20. Operatively induced chronic reflux in rats: a suitable model for studying esophageal carcinogenesis?
Gronnier C; Bruyère E; Piessen G; Briez N; Bot J; Buob D; Leteurtre E; Van Seuningen I; Mariette C
Surgery; 2013 Nov; 154(5):955-67. PubMed ID: 24084597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
